HOOKIPA Pharma Inc
NASDAQ:HOOK

Watchlist Manager
HOOKIPA Pharma Inc Logo
HOOKIPA Pharma Inc
NASDAQ:HOOK
Watchlist
Price: 1.14 USD Market Closed
Market Cap: 13.9m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

HOOK Price Targets Summary
HOOKIPA Pharma Inc

There are no price targets for HOOK.
HOOK Lowest Forecast
Wall Street Target
Not Available
HOOK Average Forecast
Wall Street Target
Not Available
HOOK Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
HOOKIPA Pharma Inc Competitors:
Price Targets
300841
Chengdu Kanghua Biological Products Co Ltd
11% Upside
DBV
DBV Technologies SA
132% Upside
2171
CARsgen Therapeutics Holdings Ltd
4% Downside
F
FLUO
Fluoguide AS
163% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
11% Upside
DBV
DBV Technologies SA
132% Upside
2171
CARsgen Therapeutics Holdings Ltd
4% Downside
F
FLUO
Fluoguide AS
163% Upside
MSB
Mesoblast Ltd
23% Upside
IMAB
I-Mab
191% Upside
MIRM
Mirum Pharmaceuticals Inc
38% Upside
VRTX
Vertex Pharmaceuticals Inc
12% Upside

Revenue
Forecast

Revenue Estimate
HOOKIPA Pharma Inc

For the last 6 years the compound annual growth rate for HOOKIPA Pharma Inc's revenue is 34%. The projected CAGR for the next 3 years is -39%.

34%
Past Growth
-39%
Estimated Growth
Estimates Accuracy
1%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
HOOKIPA Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
HOOKIPA Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-63%
Average Miss
What are analyst estimates?

See Also

Summary
HOOK intrinsic value, competitors valuation, and company profile.
DCF Valuation
HOOK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HOOK stock valuation using valuation multiples.
Wall Street Estimates
HOOK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HOOK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HOOK's stock price target?
Not Available

HOOK doesn't have any price targets made by Wall Street professionals.

What is HOOKIPA Pharma Inc's Revenue forecast?
Projected CAGR
-39%

For the last 6 years the compound annual growth rate for HOOKIPA Pharma Inc's revenue is 34%. The projected CAGR for the next 3 years is -39%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 269,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.